Shingrix
NDC 50090-7919, Zoster Vaccine Recombinant, Adjuvanted, injection, solution, from A-S Medication Solutions.
- Product NDC
- 50090-7919
- Status
- Listed
- Labeler
- A-S Medication Solutions
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Product type
- VACCINE
- Marketing category
- BLA
- Application
- BLA125614
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50090-7919 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN50 ug/.5mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50090-7919-0 | 50090791900 | 1 mL in 1 KIT (50090-7919-0) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 50090-7919 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50090-7919 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50090-7919. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.